Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 10 Key Players companies in Anticholinergic Drugs
by Highest Patent Value in the China in 2019

The Anticholinergic Drugs top 10 is Discovery PatSnap’ annual ranking of the top 10 Highest Patent Value Anticholinergic Drugs Key Players in the China. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2019, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Antispasmodic drugs with an anticholinergic effect include: Bentyl (dicyclomine) Buscopan (hyoscine butylbromide) Levsin (hyoscyamine) Lomotil (atropine/diphenoxylate) Enablex (darifenacin) Pamine (methylscopalamine) Spiriva (tiotropium bromide)
#
Company Name
Region
Tech Topics
Total
1
Hunan Dongting Pharmaceutical Co., Ltd.
Drug,Medicine
Avg patent value: 110,000
2
Wuhan Wuyao Pharmaceutical Co., Ltd.
Paclitaxel,Hydroxychloroquine
Avg patent value: 54,000
3
Tianjin Jinyao Group Co. Ltd.
Medicine
Avg patent value: 3,500
4
Xuchang Hengsheng Pharmaceutical Co. Ltd.
Avg patent value: 3,400
5
Shanghai Fangyu Health Pharmaceutical Technology Co., Ltd.
Avg patent value: 3,400
6
Jiangsu Lianhuan Pharmaceutical Co., Ltd.
Pharmaceutical manufacturing,Antibiotics,Pharmacy,
...[+2]
Avg patent value: 0
7
Chengdu List Pharmaceutical Co., Ltd.
Pharmaceutical engineering,Medicine,Biological product,
...[+1]
Avg patent value: 0
8
Shanghai SPH New Asiatic Pharmaceutical Co., Ltd.
Drug,Medicine
Avg patent value: 0
9
Shandong Luye Natural Drug Research & Development Co., Ltd.
Avg patent value: 0
10
Shanghai New Asiatic Pharmaceutical Minhang Co. Ltd.
Avg patent value: 0
Page generation time: May 14 2025